(Q36259086)

13 August 2017

1 reference

title

Opinion: What is the role of protein aggregation in neurodegeneration? (English)

1 reference

13 August 2017

1 reference

1 reference

Christopher A Ross

1

1 reference

13 August 2017

Michelle A Poirier

series ordinal

2

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Nature Reviews Molecular Cell Biology

13 August 2017

published in

1 reference

13 August 2017

volume

6

1 reference

13 August 2017

issue

11

1 reference

13 August 2017

page(s)

891-898

1 reference

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

13 August 2017

cites work

1 reference

Huntingtin aggregation and toxicity in Huntington's disease

31 March 2020

1 reference

Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases

31 March 2020

1 reference

Protein aggregation and neurodegenerative disease

31 March 2020

1 reference

Therapeutic approaches to protein-misfolding diseases

31 March 2020

1 reference

Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases?

31 March 2020

1 reference

Protein folding and misfolding

31 March 2020

1 reference

Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

31 March 2020

1 reference

Molecular Pathways of Neurodegeneration in Parkinson's Disease

31 March 2020

1 reference

Prefibrillar amyloid protein aggregates share common features of cytotoxicity.

31 March 2020

1 reference

X-ray diffraction studies on amyloid filaments

31 March 2020

1 reference

From the globular to the fibrous state: protein structure and structural conversion in amyloid formation.

31 March 2020

1 reference

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

31 March 2020

1 reference

Contribution of somal Lewy bodies to neuronal death

31 March 2020

1 reference

Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

31 March 2020

1 reference

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

31 March 2020

1 reference

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

31 March 2020

1 reference

Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.

31 March 2020

1 reference

Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis

31 March 2020

1 reference

Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons

31 March 2020

1 reference

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions

31 March 2020

1 reference

Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective

31 March 2020

1 reference

Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

31 March 2020

1 reference

Modulation of neurodegeneration by molecular chaperones

31 March 2020

1 reference

Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression

31 March 2020

1 reference

Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice

31 March 2020

1 reference

The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases

31 March 2020

1 reference

Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration

31 March 2020

1 reference

Mechanisms of chaperone-mediated autophagy

31 March 2020

1 reference

Pathophysiology of chaperone-mediated autophagy

31 March 2020

1 reference

Activation of chaperone-mediated autophagy during oxidative stress

31 March 2020

1 reference

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy

31 March 2020

1 reference

Dynein mutations impair autophagic clearance of aggregate-prone proteins

31 March 2020

1 reference

Aggresomes: a cellular response to misfolded proteins

31 March 2020

1 reference

Lewy-body formation is an aggresome-related process: a hypothesis

31 March 2020

1 reference

Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation

31 March 2020

1 reference

Involvement of macroautophagy in the dissolution of neuronal inclusions.

31 March 2020

1 reference

Emerging role for autophagy in the removal of aggresomes in Schwann cells.

31 March 2020

1 reference

Autophagy regulates the processing of amino terminal huntingtin fragments

31 March 2020

1 reference

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

31 March 2020

1 reference

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

31 March 2020

1 reference

Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.

31 March 2020

1 reference

Conformational Abs recognizing a generic amyloid fibril epitope

31 March 2020

1 reference

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

31 March 2020

1 reference

Conformational variations in an infectious protein determine prion strain differences

31 March 2020

1 reference

Birth of a prion: spontaneous generation revisited

31 March 2020

1 reference

Nucleated conformational conversion and the replication of conformational information by a prion determinant

31 March 2020

1 reference

Mechanism of prion propagation: amyloid growth occurs by monomer addition

31 March 2020

1 reference

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

31 March 2020

1 reference

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

31 March 2020

1 reference

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

31 March 2020

1 reference

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

31 March 2020

1 reference

Self-assembly of Abeta(1-42) into globular neurotoxins.

31 March 2020

1 reference

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

31 March 2020

1 reference

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways

31 March 2020

1 reference

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

31 March 2020

1 reference

Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo

31 March 2020

1 reference

Neurodegenerative disease: amyloid pores from pathogenic mutations

31 March 2020

1 reference

Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization

31 March 2020

1 reference

Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer

31 March 2020

1 reference

Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation

31 March 2020

1 reference

Mutational analysis of the structural organization of polyglutamine aggregates

31 March 2020

1 reference

A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure.

31 March 2020

1 reference

Impairment of the ubiquitin-proteasome system by protein aggregation

31 March 2020

1 reference

Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins

31 March 2020

1 reference

Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.

31 March 2020

1 reference

Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release

31 March 2020

1 reference

Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation.

31 March 2020

1 reference

Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation

31 March 2020

1 reference

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

31 March 2020

1 reference

CREB-binding protein sequestration by expanded polyglutamine

31 March 2020

1 reference

Evidence for a recruitment and sequestration mechanism in Huntington's disease

31 March 2020

1 reference

Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells

31 March 2020

1 reference

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

31 March 2020

1 reference

Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity

31 March 2020

1 reference

Amyloid ion channels: a common structural link for protein-misfolding disease

31 March 2020

1 reference

Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA).

31 March 2020

1 reference

Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations

31 March 2020

1 reference

Toward Alzheimer therapies based on genetic knowledge

31 March 2020

1 reference

Protein aggregation in motor neurone disorders.

31 March 2020

1 reference

Emerging principles of conformation-based prion inheritance

31 March 2020

1 reference

Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view

31 March 2020

1 reference

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRM1742

1 reference

13 August 2017

1 reference